116 related articles for article (PubMed ID: 3664942)
1. Postoperative systemic adjuvant chemotherapy for bladder cancer.
Kiyohara H; Kuroda M; Saiki S; Miki T; Kinouchi T; Usami M; Kotake T
Cancer Chemother Pharmacol; 1987; 20 Suppl():S34-8. PubMed ID: 3664942
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy for invasive bladder cancer.
Uekado Y; Shinka T; Hirano A; Ohkawa T
Cancer Chemother Pharmacol; 1987; 20 Suppl():S24-8. PubMed ID: 3117397
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy including adriamycin for advanced transitional cell carcinoma of the urinary tract.
Kotake T; Usami M; Miki T; Kuroda M; Obata K; Osafune M; Fujioka H; Takasugi Y
Cancer Chemother Pharmacol; 1983; 11 Suppl():S38-42. PubMed ID: 6685580
[TBL] [Abstract][Full Text] [Related]
4. Phase III trial of the Japanese Urological Cancer Research Group for Adriamycin: cyclophosphamide, adriamycin and cisplatinum versus cyclophosphamide, adriamycin and 5-fluorouracil in patients with advanced transitional cell carcinoma of the urinary bladder.
Maru A; Akaza H; Isaka S; Koiso K; Kotake T; Machida T; Matsumura Y; Nakagami Y; Niijima T; Obata K
Cancer Chemother Pharmacol; 1987; 20 Suppl():S44-8. PubMed ID: 3311445
[TBL] [Abstract][Full Text] [Related]
5. [Neoadjuvant and adjuvant chemotherapy of bladder cancer].
Kuroda M; Kotake T
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():362-9. PubMed ID: 7986116
[TBL] [Abstract][Full Text] [Related]
6. [Polychemotherapy treatment with cisplatin, adriamycin, 5-fluorouracil (FAP) and cisplatin, adriamycin and cyclophosphamide (CISCA) in advanced transitional carcinoma of the bladder].
Sánchez Romero JA; Ramírez Ruiz F; Romero Fernández L; Pastor Gaitán P; Murillo Capitán E
Actas Urol Esp; 1989; 13(4):240-2. PubMed ID: 2678934
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
8. Preoperative and postoperative adjuvant chemotherapy using CISCA (cyclophosphamide, doxorubicin, and cisplatin) in the treatment of invasive transitional-cell carcinoma of the bladder.
Lynch DF
Urol Clin North Am; 1991 Aug; 18(3):543-6. PubMed ID: 1877118
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
Stöckle M; Meyenburg W; Wellek S; Voges GE; Rossmann M; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
J Urol; 1995 Jan; 153(1):47-52. PubMed ID: 7966789
[TBL] [Abstract][Full Text] [Related]
10. The management of advanced bladder carcinoma.
Kedia KR; Gibbons C; Persky L
J Urol; 1981 May; 125(5):655-8. PubMed ID: 7194923
[TBL] [Abstract][Full Text] [Related]
11. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy for advanced bladder cancer with adriamycin, cyclophosphamide, and 5-fluorouracil.
Tashiro K; Machida T; Masuda F; Ohishi Y
Cancer Chemother Pharmacol; 1983; 11 Suppl():S43-6. PubMed ID: 6640834
[TBL] [Abstract][Full Text] [Related]
13. [Combination chemotherapy of urothelial cancer with cisplatin, cyclophosphamide, doxorubicin and peplomycin: treatment of advanced cases and adjuvant chemotherapy after radical operation].
Seguchi T; Sakaguchi H; Kajikawa H; Nishioka T
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):600-5. PubMed ID: 2435245
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant systemic chemotherapy after complete transurethral resection of superficially invasive bladder carcinoma (T1 G3-4 and T2 G2-4).
Rübben H; Weissbach L; Knebel L; Deutz FJ; Giani G; Graf-Dobberstein C; Gebhard R
Urol Int; 1990; 45(2):78-83. PubMed ID: 2184564
[TBL] [Abstract][Full Text] [Related]
15. A study of cyclophosphamide, adriamycin, cis-platinum, and methotrexate in advanced transitional cell carcinoma of the urinary tract.
Citrin DL; Hogan TF; Davis TE
Cancer; 1983 Jan; 51(1):1-4. PubMed ID: 6681590
[TBL] [Abstract][Full Text] [Related]
16. RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy.
Hagan MP; Winter KA; Kaufman DS; Wajsman Z; Zietman AL; Heney NM; Toonkel LM; Jones CU; Roberts JD; Shipley WU
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):665-72. PubMed ID: 14529770
[TBL] [Abstract][Full Text] [Related]
17. Three-drug combination chemotherapy for advanced urothelial tract carcinoma.
Ohshima S; Ono Y; Fujita T; Aso Y
Cancer Chemother Pharmacol; 1987; 20 Suppl():S20-3. PubMed ID: 2444354
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of cyclophosphamide, doxorubicin, and cisplatin (CAP) versus amsacrine in patients with transitional cell carcinoma of the urinary bladder: a Southwest Oncology Group study.
Al-Sarraf M; Frank J; Smith JA; O'Bryan RM; Costanzi JJ; Stephens RL; Caraveo J; Crawford ED
Cancer Treat Rep; 1985 Feb; 69(2):189-94. PubMed ID: 2578880
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of adjuvant chemotherapy for high stage bladder cancer.
Uekado Y; Hirano A; Shinka T; Ohkawa T
Urol Int; 1991; 47 Suppl 1():123-6. PubMed ID: 1949368
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant treatment of stages T2 to T4 bladder cancer with cis-platinum, cyclophosphamide and doxorubicin.
McCullough DL; Cooper RM; Yeaman LD; Loomer L; Woodruff RD; Boyce WH; Harrison LH; Assimos DG; Lynch DF
J Urol; 1989 Apr; 141(4):849-52. PubMed ID: 2926878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]